Topics

Arrowhead initiates Phase II/III trial of RNAi therapeutic ARO-AAT

19:00 EDT 8 Aug 2019 | Net Resources International

Arrowhead Pharmaceuticals has initiated a potentially pivotal Phase II/III clinical trial of ARO-AAT, its second generation subcutaneously administered RNA interference...
Read More...

The post Arrowhead initiates Phase II/III trial of RNAi therapeutic ARO-AAT appeared first on Drug Development Technology.

Original Article: Arrowhead initiates Phase II/III trial of RNAi therapeutic ARO-AAT

NEXT ARTICLE

More From BioPortfolio on "Arrowhead initiates Phase II/III trial of RNAi therapeutic ARO-AAT"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...